Correlation Between Tscan Therapeutics and Iridium Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Iridium Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Iridium Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Iridium Communications, you can compare the effects of market volatilities on Tscan Therapeutics and Iridium Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Iridium Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Iridium Communications.

Diversification Opportunities for Tscan Therapeutics and Iridium Communications

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tscan and Iridium is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Iridium Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iridium Communications and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Iridium Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iridium Communications has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Iridium Communications go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Iridium Communications

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Iridium Communications. In addition to that, Tscan Therapeutics is 1.29 times more volatile than Iridium Communications. It trades about -0.03 of its total potential returns per unit of risk. Iridium Communications is currently generating about 0.06 per unit of volatility. If you would invest  2,709  in Iridium Communications on September 3, 2024 and sell it today you would earn a total of  263.00  from holding Iridium Communications or generate 9.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  Iridium Communications

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Iridium Communications 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Iridium Communications are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, Iridium Communications may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Tscan Therapeutics and Iridium Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and Iridium Communications

The main advantage of trading using opposite Tscan Therapeutics and Iridium Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Iridium Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iridium Communications will offset losses from the drop in Iridium Communications' long position.
The idea behind Tscan Therapeutics and Iridium Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets